Evidence map›Paper›PMID 32715779›Full record

ArticleDrug delivery2020

IGF-1-releasing PLGA nanoparticles modified 3D printed PCL scaffolds for cartilage tissue engineering.

Peiran Wei, Yan Xu, Yue Gu, Qingqiang Yao, Jiayin Li, Liming Wang

Open access · goldAbstract read
In one paragraph

Article in Drug delivery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Peiran WeiDepartment of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yan XuDepartment of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Yue GuDepartment of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Qingqiang YaoDepartment of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Jiayin LiDepartment of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Liming WangDepartment of Orthopaedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to fabricate and test a 3D-printed PCL scaffold incorporating IGF-1-releasing PLGA nanoparticles for cartilage tissue engineering. IGF-1 loaded PLGA nanoparticles were produced by the double-emulsion method, and were incorporated onto 3D printed PCL scaffolds via PDA. Particle size, loading effciency (LE) and encapsulation effciency (EE) of the nanoparticles were examined. SEM, pore size, porosity, compression testing, contact angle, IGF-1 release kinetics of the composite scaffolds were also determined. For cell culture studies, CCK-8, Live/dead, MTT, GAG content and expression level of chondrocytes specific proteins and genes and HIF-1α were also tested. There was no difference of the nanoparticle size. And the LE and EE of IGF-1 in PLGA nanoparticles was about 5.53 ± 0.12% and 61.26 ± 2.71%, respectively. There was a slower, sustained release for all drug-loaded nanoparticles PLGA/PDA/PCL scaffolds. There was no difference of pore size, porosity, compressive strength of each scaffold. The contact angles PCL scaffolds were significant decreased when coated with PDA and PLGA nanoparticales. (

Indexed as

Guided Tissue RegenerationNanoparticlesPolylactic Acid-Polyglycolic Acid CopolymerTissue ScaffoldsAnimalsCartilageCell EncapsulationCell ProliferationCell SurvivalChondrocytesInsulin-Like Growth Factor IMesenchymal Stem CellsPolyestersPrinting, Three-DimensionalRabbitsTissue EngineeringInsulin-Like Growth Factor IpolycaprolactonePolyestersPolylactic Acid-Polyglycolic Acid Copolymer3D-printedcartilage tissue engineeringIGF-1nanoparticlesPCL

Identifiers

PMID32715779
PMCPMC7470157
OpenAlexW3043836601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.